RB1 and melanoma: Further analyses into the specific mutated regions of TERT identified upstream promoter, downstream, and intronic regions as having increased mutation frequency in melanomas that also carry mutations in the RB1 pathway compared with tumors without RB1 pathway alterations (Fig 5E).